Loading company…
Neuraly, Inc. develops disease-modifying agents for treating neurodegenerative diseases.
Founded in 2016 and based in Germantown, US, Neuraly, Inc. is a pharmaceutical company developing disease-modifying agents for neurodegenerative diseases. The company is at the Series B stage.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in